A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12–20 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Kan Anita S.Y.   Ho Pak Chung  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3062-3066

Oxford University Press

Access to resources Recommend Favorite

A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation

By Hamoda Haitham   Ashok Premila W.   Flett Gillian M.M.   Templeton Allan  

Human Reproduction, Vol. 20, Iss. 8, 2005-08 ,pp. : 2348-2354

Oxford University Press

Access to resources Recommend Favorite

Fertility control. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation

By Bartley Julia   Brown Audrey   Elton Rob  

Human Reproduction, Vol. 16, Iss. 10, 2001-10 ,pp. : 2098-2102

Oxford University Press

Access to resources Recommend Favorite

The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13–22 weeks gestation

By Fiala C.   Swahn M.L.   Stephansson O.   Gemzell-Danielsson K.  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3072-3077

Oxford University Press

Access to resources Recommend Favorite

Pregnancy and obstetrics. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability

By Ngai S.W.   Tang O.S.   Chan Y.M.  

Human Reproduction, Vol. 15, Iss. 5, 2000-05 ,pp. : 1159-1162

Oxford University Press

Access to resources Recommend Favorite